Showing results (111-120 of 145) with videos related to
Sort By:
Pageof 15
Swiss Medical Weekly|December 24, 2014
General management of nonagenarian patients: a review of the literatureRomain Rivoirard, Cyrus Chargari, Jane-Chloé Trone, et al.Chemotherapy|November 10, 2015
Chemotherapy Regimen in Nonagenarian Cancer Patients: A Bi-Institutional ExperienceRomain Rivoirard, Cyrus Chargari, Sharif Kullab, et al.Nature Medicine|April 27, 2023
Multi-organ landscape of therapy-resistant melanomaSixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, et al.Chemotherapy|April 9, 2016
Clinical Impact of Bevacizumab in Patients with Relapsed Glioblastoma: Focus on a Real-Life Monocentric SurVey (SV1 Study)Romain Rivoirard, Cyrus Chargari, Jean-Baptiste Guy, et al.Cancer Discovery|November 23, 2013
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibitionHubing Shi, Aayoung Hong, Xiangju Kong, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 13, 2016
[Carcinomatous meningitis: The radiation therapist's point of view]S Espenel, A Vallard, J Langrand-Escure, et al.Cancer Discovery|May 17, 2012
Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitorsHubing Shi, Gatien Moriceau, Xiangju Kong, et al.Cell Death & Disease|January 9, 2024
Slc20a1 and Slc20a2 regulate neuronal plasticity and cognition independently of their phosphate transport abilityMariana Ramos-Brossier, David Romeo-Guitart, Fabien Lanté, et al.Cell Discovery|September 21, 2016
JUN dependency in distinct early and late BRAF inhibition adaptation states of melanomaBjoern Titz, Anastasia Lomova, Allison Le, et al.International Urology and Nephrology|May 19, 2015
Hypofractionated radiation therapy for treatment of bladder carcinoma in patients aged 90 years and more: A new paradigm to be explored?Benoîte Méry, Alexander T Falk, Avi Assouline, et al.Pageof 15